Targeted Agents and Resistance Mechanism in Renal Cell Cancer
Journal Title: The Bulletin of Urooncology - Year 2019, Vol 18, Issue 2
Abstract
Renal cell carcinoma (RCC) exhibits multidrug resistance protein P-glycoprotein expression due to the proximal tubular origin and in this regard, it is resistant to a large number of cytotoxic chemotherapy. The identification of the molecular pathogenesis, genetics, and epigenetics of RCC has led to new target points such as vascular endothelial growth factor. Tyrosine kinase inhibitors have been used mainly for treatment, but recently, immune checkpoint inhibitors have also been used in the treatment of RCC. Despite these treatments, response rates are not sufficient in the majority of patients. Primary resistance or acquired resistance to the treatment might be seen. Defining these resistance mechanisms will contribute to the management of the treatment and will help in to identify new treatment targets. In this review, we focus on the molecular mechanisms and resistance mechanisms of targeted-therapy.
Authors and Affiliations
Shaghayegh Rezapourbehnagh, Hatime Arzu Yaşar, Çağatay Arslan, Yüksel Ürün
Keywords
Related Articles
- EP ID EP48742
- DOI 10.4274/uob.galenos.2018.1090
- Views 276
- Downloads 0
A Case of Pediatric Paratesticular Rhabdomyosarcoma Misdiagnosed as Epididymitis
Paratesticular embryonal rhabdomyosarcoma (RMS) is a rare tumor arising from the mesenchymal tissues of testis and paratesticular tissue. RMS which usually presents as a painless mass in the scrotum is frequently seen in...
Effect of Primary Testicular Tumor Localization on Prognosis and Survival of Non-seminomatous Testis Cancer Patients
Objective: Unlike left testicular vein, right testicular vein drains into inferior vena cava. Consequently, the systemic spread of testicular cancers in each side is expected to differ based on the vascular structures of...
Nuclear Medicine Applications in Diagnosis of Urological Tumors
Except for prostate carcinoma, there is limited data in the literature on the role of nuclear imaging methods in the management of urological cancers. 18F-fluorodeoxyglucose positron emission tomography/computed tomograp...
Role of Tissue Markers on Predicting the Prognosis of Intermediate and High-risk Non-muscle Invasive Bladder Cancer
Objective: Investigating the recurrence of high-risk non-muscle invasive bladder cancer patients with the phosphohistone H3 (PPH3), P53, and Ki-67 as a predictive markers. Materials and Methods: A total of 46 patients w...
Risk Factors Affecting Complications Due to Prostate Biopsy
Objective: Currently, transrectal ultrasound (TRUS) guided prostate biopsy is the standard method used for prostate cancer detection. In the last decade, hospitalization due to complications has increased, especially due...